Oxoid Legionella BCYE Growth Supplement, For 500 ml of medium, SR0110C, packaged 10 vials/box, ly...
FDA Device Recall #Z-1112-2014 — Class II — January 24, 2014
Recall Summary
| Recall Number | Z-1112-2014 |
| Classification | Class II — Moderate risk |
| Date Initiated | January 24, 2014 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Remel Inc |
| Location | Lenexa, KS |
| Product Type | Devices |
| Quantity | 44/10/500-ml. vial boxes |
Product Description
Oxoid Legionella BCYE Growth Supplement, For 500 ml of medium, SR0110C, packaged 10 vials/box, lyophilized. The firm name on the label is Oxoid Ltd., Basingstoke, Hants, England. The product is used for the isolation of Legionella species from clinical and environmental samples. When the product is added to CYE Agar base, it stabilizes pH and provides essential growth factors for the isolation of the Legionella spp.
Reason for Recall
The product may contain high levels of microbial contamination
Distribution Pattern
US Distribution including Puerto Rico and the states of FL, IL, MA, ME, MI, and PA.
Lot / Code Information
Lot 1380784, Exp. 31Aug2015, and Lot 1367905, Exp. 31Jul2015
Other Recalls from Remel Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0331-2023 | Class I | Thermo SCIENTIFIC, Sensititre CMC5VGNF, Gram Ne... | Oct 20, 2022 |
| Z-0334-2023 | Class I | Thermo SCIENTIFIC, Sensititre STP6F, Gram Negat... | Oct 20, 2022 |
| Z-0330-2023 | Class I | Thermo SCIENTIFIC, Sensititre HPB1, Gram Negati... | Oct 20, 2022 |
| Z-0329-2023 | Class I | Thermo SCIENTIFIC, Sensititre GN7F, Gram Negati... | Oct 20, 2022 |
| Z-0327-2023 | Class I | Thermo SCIENTIFIC Sensititre Plate, GN4F, Gram ... | Oct 20, 2022 |
Frequently Asked Questions
Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.